Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes

Area of Science:

• Genetics
• Endocrinology
• Molecular Biology

Background:

• Monogenic diabetes forms arise from genetic defects in pancreatic beta-cell function.
• These conditions manifest from infancy through young adulthood with diverse genetic causes.
• Known genetic subtypes include neonatal diabetes mellitus and other early-onset diabetes forms.

Purpose of the Study:

• To review advances in identifying genetic and molecular mechanisms of monogenic diabetes in the young.
• To explore how genetic insights inform novel pharmacogenomic approaches for diabetes treatment.
• To highlight the link between monogenic diabetes genes and susceptibility to type 2 diabetes.

Main Methods:

• Identification of over ten genes highly expressed in pancreatic beta-cells.
• Analysis of aetiological mechanisms including beta-cell number, glucose sensing, and destruction.
• Review of clinical features and genetic underpinnings of various early-onset diabetes conditions.

Main Results:

• Established genetic heterogeneity in monogenic diabetes with multiple identified genes.
• Revealed diverse beta-cell dysfunction mechanisms leading to impaired insulin secretion.
• Growing evidence suggests common polymorphisms in these genes influence type 2 diabetes risk.

Conclusions:

• Genetic discoveries have elucidated mechanisms of beta-cell dysfunction in monogenic diabetes.
• These insights are paving the way for personalized pharmacogenomic treatments.
• Further research into gene variants may clarify susceptibility to common adult-onset diabetes.